Dermatological problems in kidney recipients in Yazd Province, Iran
Keywords:
Kidney transplant, dermatological side- effects, immunosuppressive drugsAbstract
Background Kidney transplantation is one of the effective methods to treat kidney disease. In a kidney transplant, due to the use of many immunosuppressive drugs, the body is often subjected to various benign, premalignant and malignant dermatoses. The early diagnosis and effective treatment of such conditions can potentially reduce morbidity and mortality. Objective To determine the distribution of dermatoses in patients who have received kidney transplants. Patients and methods This cross-sectional study was performed on 120 kidney transplant recipients in Yazd University Hospitals in two years. The patients were examined by a dermatologist and diagnosis was made on the basis of clinical observations. Biopsies and scraping of the lesions were taken whenever necessary. Results 120 evaluable patients included 84 males and 36 females with mean age of 32 years. A total of 116 patients developed dermatological symptoms, which included: hypertrichosis (78.3%), photosensitivity (70%), cushingoid face (60%), gingival hyperplasia (43.3%), warts (40%), pityriasis versicolor (33.3%), steroidal acne (26.6%), herpes simplex (13.3%), herpes zoster (10%), nonmelanoma cancer (10%), oral candidiasis (6.6%), striae (6.6%), actinic keratosis (6.6%) and sebaceous hyperplasia (3.3%). Conclusion Skin lesions are a significant problem in kidney transplant recipients. A careful monitoring of these patients is recommended in order to detect these lesions in early stages and treat them.ÂReferences
Penn I. Tumors of the immunocompromised patient. Annu Rev Mee 1988; 39: 63-73.
Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767-9.
Carpenter CB, Milford EL, Sayegh MH. Transplantation in the treatment of renal failure. In: Kasper DL, Braunwald E, Fauci AS et al, editors. Harrison’s principles of internal medicine. 16th edn. New York: Mc Graw- Hill; 2005. P.1668-74.
Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.
Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86.
Boyle J, Mackie RM, Briggs JD et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1: 703-5.
Mclelland J, Ress A, Williams G, Chu T. The incidence of immunosuppression- related skin disease in long-term transplant patients. Transplantation 1998; 46: 871-4.
Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122: 1288-93.
Hintner H, Fritsch P. Skin neoplasia in the immunodeficient host. The clinical spectrum: Kaposi’s sarcoma, Iymphoma, skin cancer and melanoma. Curr Probl Dermatol 1989; 18: 210-7.
Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal transplant recipients. Lancet 1981; 1: 1196-9.
Spencer ES, Andersen HK. Viral infections in renal allograft recipients treated with long-term immunosuppression. Br Med J 1979; 2: 829-30.
Rafi A, Ghacha R, Sinha A et al. Spectrum of skin diseases in renal transplant recipients. Dia Transplant 2001; 30: 282-5.
Lugo–Janer G, Sanchez JL, Santiago-Delpin E. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol 1991; 24: 410-4.
Bencini PL, Montagnino G, Sala F et al. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica 1986; 172: 24-30.
Lesnoni La Parola I, Citterio F et al. Skin manifestations in 140 kidney transplants. Recenti Prog Med 1992; 83: 61-3. [Italian].
Chugh KS, Sharma SC, Singh V et al. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment. Dermatology 1994; 188: 108-12.
Hepburn DJ, Divakar D, Bailey RR, Macdonald KJ. Cutaneous manifestations of renal transplantation in a New Zealand population. N Z Med J 1994; 107: 497-9.
Rudlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115: 681-92.
Virgili A, Zampino MR, La Malfa V et al. Prevalence of superficial dermatomycoses in 73 renal transplant recipients. Dermatology 1999; 199: 31-4.
Gulec AT, Demirbilek M, Seckin D et al. Superficial fungal infections in 102 renal transplant recipients: a case – control study. J Am Acad Dermatol 2003; 49: 187-92.
Dreno B. Skin cancers after transplantation. Nephrol Dial Transplant 2003; 18: 1052-8.
Cohen EB, Komorowski RA, Clowry LJ. Cutaneous complications in renal transplant recipients. Am J Clin Pathol 1987; 88: 32-7.
Bordea C, Wojnarowska F, Millard PR et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77: 574-9.
Marcen R, Pascual J, Tato AM et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003; 35: 1714-6.
Lindelof B, Granath F, Dal H et al. Sun habits in kidney transplant recipients with skin cancer: a case- control study of possible causative factors. Acta Derm Venereol 2003; 83: 189-93.
Ramsay HM, Fryer AA, Hawley CM et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49: 397-406.
Bunney MH, Benton EC, Barr BB et al. The prevalence of skin disorders in renal allograft recipients receiving cyclosporine. A compared with those receiving azathioprine. Nephorl Dial Transplant 1990; 5: 379-82.
